Whole Foods Market Daily Shop will be smaller and more convenient. Courtesy rendering

Texas-based Whole Foods Market is unrolling a new kind of store for urban neighborhoods that'll be smaller and quicker than its current mega-model.

Called Whole Food Market Daily Shop, it'll be designed as a quick, convenient shopping experience, targeted to urban neighborhoods. According to a release, the new format will debut in Manhattan's Upper East Side at 1175 Third Ave. in 2024, with additional locations in New York to follow.

Following the New York city launch, the chain will bring the format to other cities across the U.S.

The stores will range from 7,000-14,000 square feet — about a quarter to half the size of the average 40,000-square-foot Whole Foods Market — making it easier to open in dense, metropolitan areas.

Whole Foods Market Daily Shop will feature grab-and-go meals and snacks, weekly essentials, and a quick, easy destination to pick up ingredients to complete a meal.

Though smaller, the stores will still offer produce, meat, and seafood; prepared foods like sandwiches and pre-packed meals; bread, alcohol, and supplements; plus products under the 365 by Whole Foods Market private label.

The first location only will also feature a venue called Juice & Java, with coffee, tea, juices, smoothies, sandwiches, soups, and desserts.

Whole Foods VP Christina Minardi says in a statement that the store's design reflects the unique needs of urban neighborhoods.

“At our new store formats, we’re tailoring every square foot to the unique, fast-paced needs of urban lifestyles," Minardi says. "We’re excited to introduce a new way for our customers to quickly pick up their Whole Foods Market favorites — from grab-and-go meals to that last-minute dinner ingredient — making the early morning or after work grocery trips more efficient and enjoyable."

This is not WFM's first effort to expand beyond the traditional supermarket footprint. In 2016, the chain introduced 365 by Whole Foods Market, a lower-price concept designed to appeal to younger shoppers. It went on to open nine locations, but scrapped the concept in 2019, following its acquisition in 2017 by Amazon.

The new format stores will not replace traditional or existing store locations. New York currently has 17 regular stores, including the most recent added at One Wall Street in 2023. The chain, which was founded in Austin in 1980, currently has more than 530 stores in the U.S., U.K., and Canada with another 75-plus stores in the pipeline, and is part of Amazon’s Worldwide Grocery Stores.

------

This article originally ran on CultureMap.

Amazon Dash Cart is now available at a Whole Foods in Texas. Courtesy Amazon

Smart carts roll into Texas grocery store

hi, tech

If being more efficient with your time is one of your new year's goals, a faster way to shop is on the horizon in 2023.

Amazon Dash Cart just arrived at one local San Antonio Whole Foods Market, allowing shoppers to skip the checkout line altogether.

Located at 18403 Blanco Road, the Vineyard Whole Foods Market store is one of the first three locations in the country to make Amazon Dash Carts available to customers.

The smart grocery carts lets you scan items as you go, place them directly into your grocery bags, and head straight to the car when you're done shopping. Shoppers log in through a QR code in the Whole Foods Market app, which prompts a quick sign in process before you can begin using the cart.

As you scan each item while shipping, the Amazon Dash Cart’s screen shows a real-time receipt of all items in the cart. When ready to check out, shoppers can skip the checkout line, exiting the store through the designated Amazon Dash Cart lane. Payment is then processed using the credit card associated with the shopper's Amazon account, and an automated receipt arrives at the associated email account after exiting the store.

While the carts have been in Amazon Fresh Stores across the country since 2020, they are now available in select Whole Foods Markets. Several 2022 updates included doubled capacity in the carts, new shelves for delicates and oversized items alike, weather-resistant features, and extended all-day batter life.

"As many of our customers return to their in-store grocery shopping routines, it's exciting to introduce new and unique ways for them to shop our stores," says Leandro Balbinot, chief technology officer for Whole Foods Market, in the 2022 announcement about the carts' new features.

Customers can find more detailed information on the technology here, along with a number of FAQs.

------

This article previously ran on CultureMap.

Shop smarter with these tech-enabled carts. Image via Amazon

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston researchers develop dissolvable implant for targeted cancer drug delivery

cancer research

Researchers at Houston Methodist have developed a biodegradable implant that can be used to safely and consistently deliver drug treatments to tumors and then dissolve without the need for further surgery.

The implant is only the size of a grain of rice, but its potential is staggering. The biodegradable nanofibrous drug-eluting seed (b-NDES) works as a reservoir parked inside a soft tumor, where it can slowly release immune-stimulating drugs over time. This overcomes a consistent problem with drugs such as immune checkpoint inhibitors. Normal systemic administration sees comparatively little of the drug making its way to the tumor, with most of it circulating throughout the body. The b-NDES is like deploying a small guerrilla fighting force embedded in enemy territory, doing maximum damage to the entrenched tumor.

"To improve cancer treatment, we're trying to start a fire inside the tumor itself," Corrine Chua, associate professor in the Center for BioNanoengineering at Houston Methodist Research Institute, said in a news release. "By activating immune cells directly within the tumor microenvironment, those cells can then travel throughout the body and seek out cancer wherever it exists. The b-NDES platform was developed to help keep therapeutic drugs concentrated inside tumors while minimizing exposure to healthy tissues.”

Chua co-led the study with Alessandro Grattoni, chair and director of the Center for BioNanoengineering at Houston Methodist Research Institute.

The study included support from the Nancy Owens Breast Cancer Foundation and the National Institutes of Health/National Cancer Institute.

Chau and Grattoni used preclinical models of triple-negative breast cancer, an aggressive form of cancer that is estrogen receptor-negative, progesterone receptor-negative and HER2-negative. Because of the receptor negativity, some popular treatments like tamoxifen and trastuzumab are ineffective. Chemotherapy has been shown to be the best course of action.

The b-NDES implant is deployed alongside radiation drugs. It keeps the drugs focused on the tumor, reducing the amount of harmful side effects typically seen when drugs are circulated more widely in the body. In 60 percent of the models, tumors were eliminated and did not cause side effects beyond the tumor site. Once the drugs have been deployed, the implant breaks down naturally.

While promising, more research will have to be done to expand use to other tumor types.

"Although the study focused on triple-negative breast cancer models, the approach could have broader applications for solid tumors," Grattoni added in the release. "It could potentially be used in cancers where there is a tumor lesion accessible for placement, including pancreatic or lung cancers."

New Houston platform Same Day Reels launches for on-demand content creation

In The Moment

If an event doesn't happen on Instagram, did it even really happen? In today's social media-driven age of branding and audience engagement, the answer increasingly is no.

Houston entrepreneur Karen De Amat is looking to fill the online content creation needs of companies with her new venture, Same Day Reels, which launched in early August. It will serve as a platform to connect companies and brands with talent that can help turn an event into a viral moment as it is happening.

"Events move quickly, and social media moves even faster,” said De Amat. “Same Day Reels was built to help brands capture the moment while it still matters. We are creating a more efficient way for businesses and creators to work together. Brands need content faster, and creators need more opportunities to turn their talent into real work. Same Day Reels brings those needs together.”

The company is focused on adding livestreams and concurrent short video content to "activations, launches, fundraisers, grand openings, conferences, hospitality experiences, and private celebrations." Such content can significantly increase the visibility of a product or brand according to digital marketing brands like Wyzowl, whose data found 63 percent of people in 2026 prefer to learn about new products via short video.

Packages offered by Same Day Reels will include filming, editing, and publishing content within hours of the targeted event.

De Amat says that her content creation platform will be a way to preserve the excitement of events and launches by enshrining them with immediate social media-driven memories.

“Event content is no longer just something you post after the fact,” De Amat said. “It is part of how people experience, remember and share the moment.”

Previously, De Amat is also the founder and CEO of Social Behavior, an influencer marketing company she launched from her home in 2014. It quickly garnered an array of clients and thrust De Amat into the spotlight, including numerous appearances on Fox 26's The Isiah Factor. Influencer Marketing Hub named her one of the top CEOs of influencer marketing companies in Houston in 2025.

---

This article originally appeared on CultureMap.com.

Bristol Myers Squibb to build $2.3B Houston pharma manufacturing campus

coming soon

New Jersey-based pharmaceutical giant Bristol Myers Squibb Co. has officially named Houston as the home of its new state-of-the-art manufacturing site.

The 60,000-square-foot facility represents a $2.3 billion investment, according to a news release. It is expected to create 500 skilled jobs and will be located in Houston's Generation Park.

BMS first announced that it was considering Houston among 16 other cities for the facility in May. The new hub will manufacture small molecule, biologic and antibody-drug conjugates and is part of a $40 billion commitment to invest in the United States over five years. Construction is slated to begin next year, with the facility coming online in 2030.

"We're building the domestic manufacturing capabilities needed to deliver the next generation of medicines and support future scientific breakthroughs. Houston and the state of Texas offer the talent, infrastructure, and partnership needed to help bring that vision to life," Christopher Boerner, CEO and board chair of BMS, said in the release.

The new facility will feature a modular, multi-modal design, which will allow the company to reconfigure and add to its manufacturing capabilities over time. BMS says it expects the facility to "(grow) in scale and capability well beyond its opening configuration."

"Our decision to build this state-of-the-art manufacturing campus in Houston, Texas, reflects our confidence in the region’s ability to support a world-class, digitally advanced supply operation,” Karin Shanahan, EVP and chief supply chain and operations officer of BMS, added in the release. “This facility is designed to deliver the speed, quality, and reliability that patients depend on, combining flexible, modular manufacturing with advanced digital capabilities to ensure consistent supply across multiple modalities. It strengthens our ability to operate with resilience and positions us to reliably deliver medicines to patients today while adapting future demands.”

Texas Gov. Greg Abbott shared that the state has granted BMS a $4.89 million Texas Enterprise Fund (TEF) grant for the project. TEF grants, administered by the Texas Economic Development & Tourism Office, support business relocation or expansion projects that create "new, good-paying jobs in the community and attract significant new capital investment to the state." The development is also a qualified project under the Texas Jobs, Energy, Technology, and Innovation (JETI) program.

“Texas is a global hub for life sciences, where today’s innovations shape the future of healthcare,” Abbott said in a news release. “This $2.3 billion investment by Bristol Myers Squibb in the dynamic biotech ecosystem in Houston is a testament to the depth of our skilled workforce and the pipeline of talent coming through our nation-leading technical colleges and research universities. With lower operating costs and easy access to markets across the U.S. and the world, Texas drives affordability for consumers.”

"Bristol Myers Squibb’s announcement is a tremendous win for Texas and the Houston region, further reinforcing our position as a premier destination for life sciences and advanced manufacturing,” added Greater Houston Partnership President and CEO Steve Kean.

Last fall, Eli Lilly and Co. selected Generation Park, a 4,300-acre, master-planned commercial district near Lake Houston, for its $6.5 billion manufacturing plant. More than 300 locations in the U.S. competed for the factory. Read more here.